期刊文献+

S-100蛋白在恶性间皮瘤中的分布及其意义 被引量:2

DISTRIBUTION AND SIGNIFICANCE OF S-100 PROTEIN IN MALIGNANT MESOTHE-LIOMAS
下载PDF
导出
摘要 应用S-100蛋白对恶性间皮瘤16例和腹膜转移性胃肠道腺癌20例进行了免疫组化研究。其结果表明,恶性间皮瘤16例对S-100蛋白染色阳性者有14例,而腹膜转移性胃肠道腺癌均呈阴性。作者认为,由于S-100蛋白标准化抗体有市售,无论在尸检标本或手术切除标本中,当恶性间皮瘤与腹膜转移性胃肠道腺癌鉴别诊断发生困难时,不妨使用这种肿瘤标记物的免疫组化法以助诊断。 Immunohistological methods were used to investigate the presence of s-100 protein in 16 cases of malignant mesothelioma (MM) and 20 metastatic gastrointestinal adenocarcinoma of peritoneum. Positive staining for s-100 protein was observed in 14 of 16 MM, while it was negative in all metastatic gastrointestinal adenocarcinoma of peritoneum. Since antibodies to s-100 protein are readily available as standardised commercial products, the combined immunolocalisalion of s-100 protein should prove to be an efficient routine means of differentiating MM from difficult cases of metastatic gastrointestinal adenocarcinoma of peritoneum, in both necropsy and surgical cases.
作者 于国 李维华
出处 《解放军医学杂志》 CAS CSCD 北大核心 1991年第3期186-188,共3页 Medical Journal of Chinese People's Liberation Army
关键词 S-100蛋白 恶性间皮瘤 腺癌 S-100 protein Malignant mesothelioma Adenocarcinoma
  • 相关文献

参考文献2

  • 1于国,李维华.恶性间皮瘤的超微结构诊断和鉴别诊断[J]解放军医学杂志,1988(04).
  • 2Domenico Cocchia,Libero Lauriola,Vito M. Stolfi,Giovanni Tallini,Fabrizio Michetti. S-100 antigen labels neoplastic cells in liposarcoma and cartilaginous tumours[J] 1983,Virchows Archiv A Pathological Anatomy and Histopathology(2):139~145

同被引文献23

  • 1于国,李维华,于占洋.恶性间皮瘤的病理形态学研究[J].临床与实验病理学杂志,1993,9(1):4-7. 被引量:23
  • 2于国,孙玉芝,李维华,巴恩平,昝世明,张曙光.恶性间皮瘤超微结构形态测量研究[J].解放军医学杂志,1994,19(5):377-378. 被引量:3
  • 3高杰,于国,钟梅.猿猴病毒(SV40)在恶性间皮瘤组织中表达的意义[J].诊断病理学杂志,2006,13(1):59-62. 被引量:4
  • 4于国,孙玉芝,李冰,宋志刚.19例恶性间皮瘤细针穿刺活检及细胞学诊断[J].解放军医学杂志,2006,31(3):260-261. 被引量:3
  • 5Attanoos RL,Gibbs AR.Pathology of malignant mesothelioma.Histopathology,1997,30(5):403
  • 6Wirth PR,Legier J,Wright GL,et al.Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.Cancer,1991,67:655
  • 7Sheibani K,Esteban JM,Bailey A,et al.Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma.Hum Pathol,1992,23(2):107
  • 8Doglioni C,Tos AP,Laurino L,et al.Calretinin:a novel immunocytochemical marker for mesothelioma.Am J Surg Pathol,1996,20(9):1037
  • 9Suster S,Moran CA.Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.Adv Anat Pathol,2006,13(6):316
  • 10Hassan R,Alexander R,Antman K,et al.Current treatment options and biology of peritoneal mesothelioma:meeting summary of the first NIH peritoneal mesothelioma:meeting summary of the first NIH peritoneal mesothelioma conference.Ann Oncol,2006,17(11):1615

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部